DK1562976T3 - Syntese af estetrol via estron-afledte steroider - Google Patents

Syntese af estetrol via estron-afledte steroider

Info

Publication number
DK1562976T3
DK1562976T3 DK03772962T DK03772962T DK1562976T3 DK 1562976 T3 DK1562976 T3 DK 1562976T3 DK 03772962 T DK03772962 T DK 03772962T DK 03772962 T DK03772962 T DK 03772962T DK 1562976 T3 DK1562976 T3 DK 1562976T3
Authority
DK
Denmark
Prior art keywords
estetrol
estrone
synthesis
derived steroids
group
Prior art date
Application number
DK03772962T
Other languages
English (en)
Inventor
Mark Theodoor Verhaar
Thomas Koch
Erwin Gerardus Jacobus Warmerdam
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of DK1562976T3 publication Critical patent/DK1562976T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK03772962T 2002-11-08 2003-11-07 Syntese af estetrol via estron-afledte steroider DK1562976T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079676 2002-11-08
PCT/NL2003/000782 WO2004041839A2 (en) 2002-11-08 2003-11-07 Synthesis of estetrol via estrone derived steroids

Publications (1)

Publication Number Publication Date
DK1562976T3 true DK1562976T3 (da) 2010-08-16

Family

ID=32309415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03772962T DK1562976T3 (da) 2002-11-08 2003-11-07 Syntese af estetrol via estron-afledte steroider

Country Status (13)

Country Link
US (3) US20060211669A1 (da)
EP (1) EP1562976B1 (da)
CN (1) CN100343269C (da)
AT (1) ATE469165T1 (da)
AU (1) AU2003279624A1 (da)
CA (1) CA2505190C (da)
CY (1) CY1110237T1 (da)
DE (1) DE60332754D1 (da)
DK (1) DK1562976T3 (da)
ES (1) ES2346053T3 (da)
PT (1) PT1562976E (da)
SI (1) SI1562976T1 (da)
WO (1) WO2004041839A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11053274B2 (en) * 2011-06-01 2021-07-06 Estetra S.P.R.L. Process for the production of estetrol intermediates
LT2714712T (lt) * 2011-06-01 2016-11-25 Estetra S.P.R.L. Estetrolio tarpinių junginių gamybos būdas
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EA028780B1 (ru) 2011-08-11 2017-12-29 Эстетра С.П.Р.Л. Применение эстетрола в качестве экстренного контрацептива
HUE028963T2 (en) 2011-10-07 2017-01-30 Estetra Sprl Process for the preparation of estetrol
WO2013034780A2 (en) 2012-12-20 2013-03-14 Crystal Pharma, S.A.U. Process for the preparation of estetrol and related compounds
WO2015040051A1 (en) * 2013-09-18 2015-03-26 Crystal Pharma, S.A.U. Process for the preparation of estetrol
ES2877186T3 (es) 2015-06-18 2021-11-16 Estetra Sprl Comprimido orodispersable que contiene estetrol
US11147771B2 (en) 2015-06-18 2021-10-19 Estetra Sprl Orodispersible dosage unit containing an estetrol component
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
PL3310346T3 (pl) 2015-06-18 2021-10-25 Estetra Sprl Dyspergowalna w ustach tabletka zawierająca estetrol
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
MY197942A (en) * 2017-08-01 2023-07-25 Fund Sa Adjuvant therapy for use in prostate cancer treatment
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu) * 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
IT201900017414A1 (it) 2019-09-27 2021-03-27 Ind Chimica Srl Processo per la preparazione di (15α,16α,17β)-estra-1,3,5(10)-triene-3,15,16,17-tetrolo (Estetrolo) ed intermedi di detto processo
CN114514237A (zh) * 2019-09-27 2022-05-17 工业化学有限公司 用于制备(15α,16α,17β)-雌-1,3,5(10)-三烯-3,15,16,17-四醇(雌四醇)的工艺及所述工艺的中间体
IT201900021879A1 (it) 2019-11-22 2021-05-22 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROLO (ESTETROLO) ED INTERMEDI DI DETTO PROCESSO
IT202100019631A1 (it) 2021-07-23 2023-01-23 Newchem S P A Metodo per produrre estetrolo e i suoi intermedi
WO2023021026A1 (en) 2021-08-17 2023-02-23 Aspen Oss B.V. A synthetic pathway to estra-1,3,5(10)-triene-3,15a,16a,17b-tetrol
CA3232558A1 (en) 2021-10-01 2023-04-06 Roberto Lenna Process for preparing (15alpha,16alpha,17 eta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol (estetrol) monohydrate
WO2023209017A1 (en) 2022-04-26 2023-11-02 Mithra R&D Sa Process for the production of estetrol intermediates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138588A (en) * 1962-08-24 1964-06-23 American Home Prod 17-ketals of estrone and derivatives thereof
US3177206A (en) * 1963-03-07 1965-04-06 American Home Prod Selective bromination of a-ring aromatic 17-ketalized steroids
US3433785A (en) * 1966-07-11 1969-03-18 Sterling Drug Inc 15,16-disubstituted aromatic steroids,intermediates and processes
US3673180A (en) * 1970-06-18 1972-06-27 Merck & Co Inc 19-nor-6,6-ethylene-20-spiroxenes
DD144266A1 (de) * 1979-06-13 1980-10-08 Helmut Kasch Verfahren zur herstellung von delta hoch 15-17-ketosteroiden der oestran-und androstanreihe
US4739078A (en) * 1984-02-17 1988-04-19 The Upjohn Company Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
US5340586A (en) * 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
WO2002094276A1 (en) 2001-05-18 2002-11-28 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
DE60223795T2 (de) 2001-05-23 2008-11-27 Pantarhei Bioscience B.V. Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption
ATE449606T1 (de) 2001-05-23 2009-12-15 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
WO2003018026A1 (en) 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
PT1446128E (pt) 2001-11-15 2007-03-30 Pantarhei Bioscience Bv Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição
EP2204445B1 (de) 2005-07-25 2013-01-02 RiboxX GmbH Verfahren und Kit zur primer-abhängigen Amplifikation heterologer viraler, eukaryontischer oder prokaryontischer RNA
GB0621926D0 (en) 2006-11-03 2006-12-13 Medlock Medical Ltd Multi directional stretch tubular bandages
EP2077272A1 (en) 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
EP2077273B1 (en) 2007-12-31 2011-09-14 Animal Technology Institute Taiwan Methods for separating casein from soluble proteins in a composition

Also Published As

Publication number Publication date
CN100343269C (zh) 2007-10-17
ATE469165T1 (de) 2010-06-15
WO2004041839A2 (en) 2004-05-21
CN1735627A (zh) 2006-02-15
US20180265540A1 (en) 2018-09-20
EP1562976B1 (en) 2010-05-26
CA2505190A1 (en) 2004-05-21
CY1110237T1 (el) 2015-01-14
PT1562976E (pt) 2010-08-12
SI1562976T1 (sl) 2010-08-31
EP1562976A2 (en) 2005-08-17
DE60332754D1 (de) 2010-07-08
WO2004041839A8 (en) 2005-07-21
AU2003279624A1 (en) 2004-06-07
CA2505190C (en) 2012-07-10
US10000524B2 (en) 2018-06-19
US20150105362A1 (en) 2015-04-16
WO2004041839A3 (en) 2004-07-01
US20060211669A1 (en) 2006-09-21
ES2346053T3 (es) 2010-10-08

Similar Documents

Publication Publication Date Title
CY1110237T1 (el) Συνθεση οιστετρολης δια στεροειδων προερχομενων απο οιστρονη
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
NO20054669L (no) Substituerte kinobenzoxazinanaloger
ATE452882T1 (de) Herstellung von quetiapin
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
NO20071634L (no) Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner
ATE425121T1 (de) Verfahren zur umwandlung von polysulfanen
DK1325022T3 (da) Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)
IS6876A (is) Aðferð til að framleiða mesýlöt af píperasín afleiðum
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60225595D1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
NO20053208D0 (no) Metode for reduktiv dehalogenering.
DK1255745T3 (da) Syntese af vandoplöseligt 9-dihydro-paclitaxel afledninger fra 9-dihydro-13-acetylbaccatin III
DK1339703T3 (da) Fremgangsmåde til fremstilling af paclitaxel
DK1343808T3 (da) Fremgangsmåde til syntese af et LHRA-peptid
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.
DK1280752T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler
MY143831A (en) Insecticidal incense composition, and emulsion and process for producing the same
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
AR027751A1 (es) Proceso para la n-formilacion selectiva de n-hidroxilaminas
PT1501516E (pt) Processo para a preparacao de cloridrato de benazepril